Subscribe To
Cara therapeutics faces uncertainty despite potential reimbursement extension for korsuva
Cara Therapeutics' Korsuva injection, approved for treating pruritus in adults with chronic kidney disease, may have its reimbursement period extended...
July 14, 2023, 5:11 pm
Kapruvia® (difelikefalin) recommended by england’s nice for the treatment of adults with moderate-to-severe ckd-associated pruritus
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chro...
May 18, 2023, 6:00 am